Table II.
Eosinophils in nasal lavage and induced sputum.
| Sample | Healthy subjects (n=11) | AR only (n=25) | CARAS initially presenting with AR (n=22) | CARAS initially presenting with asthma (n=15) | P-value |
|---|---|---|---|---|---|
| Nasal lavage | |||||
| Eosinophils (%) | 4.32±6.35 | 37.82±29.13a | 46.73±25.19a | 41.02±27.85a | <0.05 |
| Neutrophils (%) | 81.60±29.88 | 49.88±31.14a | 50.41±26.10a | 56.98±26.54a | <0.05 |
| Induced sputum | |||||
| Eosinophils (%) | 0.20±0.27 | 4.59±4.21 | 17.34±13.49a,b | 17.19±12.97a,b | <0.05 |
| Neutrophils (%) | 58.90±21.47 | 68.11±24.58 | 58.32±27.12 | 59.93±21.56 | >0.05 |
Data are expressed as the mean ± standard deviation.
a
P<0.05 vs. healthy subjects.
b
P<0.05 vs. AR only. AR, allergic rhinitis; CARAS, combined allergic rhinitis and asthma syndrome.